Bionomics (OTCMKTS:BNOEF) Lowered to Neutral at HC Wainwright

HC Wainwright downgraded shares of Bionomics (OTCMKTS:BNOEF) from a buy rating to a neutral rating in a research note released on Wednesday, June 26th, The Fly reports.

BNOEF stock remained flat at $$0.01 on Wednesday. The company had a trading volume of 35,750 shares, compared to its average volume of 2,113. Bionomics has a 1 year low of $0.01 and a 1 year high of $0.70. The firm’s 50-day simple moving average is $0.04.

About Bionomics

Bionomics Limited, a clinical-stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancer in Australia, France, and the United States. It operates through Drug Discovery and Development, and Contract Services segments.

Further Reading: Momentum Indicator: Relative Strength Index

The Fly

Receive News & Ratings for Bionomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionomics and related companies with MarketBeat.com's FREE daily email newsletter.